Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
General Transcription Factors01:30

General Transcription Factors

6.6K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

16.2K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.2K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

1.3K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LSD1 inhibition ameliorates congenital dyserythropoietic anemia type II.

Science translational medicine·2026
Same author

Lipid metabolism transcriptomic signature of defective erythropoiesis in Diamond Blackfan anemia syndrome.

Blood advances·2026
Same author

Changes in cell size occur across brain regions in the aging <i>Drosophila</i> brain.

bioRxiv : the preprint server for biology·2025
Same author

Genome-wide association and linkage analysis of histidine-rich glycoprotein identifies common variants associated with plasma histidine-rich glycoprotein concentrations.

Research and practice in thrombosis and haemostasis·2025
Same author

A window of cell cycle plasticity enables imperfect regeneration of an adult postmitotic organ in <i>Drosophila</i>.

bioRxiv : the preprint server for biology·2025
Same author

Evidence for Transcriptomic Conservation Between the Main Cells of the <i>Drosophila</i> Prostate-Like Accessory Gland and Basal Cells of the Mammalian Prostate.

bioRxiv : the preprint server for biology·2025
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

CRISPR-Mediated Reorganization of Chromatin Loop Structure
09:20

CRISPR-Mediated Reorganization of Chromatin Loop Structure

Published on: September 14, 2018

13.0K

p27Kip1 regulates γ-globin production.

Ginette Balbin-Cuesta1,2, Claire Drysdale2,3, Claire Kerpet4

  • 1Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI.

Blood
|December 18, 2025
PubMed
Summary
This summary is machine-generated.

Researchers found that inhibiting CDK4/6 increases fetal hemoglobin (HbF) production, offering a potential new therapy for sickle cell disease (SCD) and beta-thalassemia.

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.4K
Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.2K

Related Experiment Videos

Last Updated: Jan 8, 2026

CRISPR-Mediated Reorganization of Chromatin Loop Structure
09:20

CRISPR-Mediated Reorganization of Chromatin Loop Structure

Published on: September 14, 2018

13.0K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.4K
Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.2K

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • Sickle cell disease (SCD) and β-thalassemia are severe genetic blood disorders.
  • Fetal hemoglobin (HbF) induction can ameliorate these conditions.
  • Safe and effective HbF inducers are needed.

Purpose of the Study:

  • To identify molecular mechanisms that induce fetal hemoglobin (HbF) expression.
  • To explore cyclin-dependent kinase inhibitors (CDKIs) as potential HbF inducers.

Main Methods:

  • CRISPR activation (CRISPRa) screening of CDKIs.
  • Analysis of CDKN1B (p27Kip1) function and CDK4/6 inhibition.
  • Murine models of SCD treated with palbociclib.
  • Assessment of hydroxyurea's mechanism.

Main Results:

  • Overexpression of CDKN1B (p27Kip1) transcriptionally induces γ-globin.
  • p27Kip1's HbF induction relies on its cell cycle inhibitory functions.
  • Inhibiting CDK4/6 increases HbF, independent of BCL11A and ZBTB7A.
  • Palbociclib increases HbF in a murine SCD model.
  • Hydroxyurea may partially act via CDK4/6 inhibition.

Conclusions:

  • CDK4/6 activity is causally linked to γ-globin production.
  • CDK4/6 inhibitors represent a promising therapeutic strategy for SCD and β-thalassemia.